Pristinamycin in-vitro activity against Staphylococcus aureus and evaluation of proposals for interpreting diffusion susceptibility data according to Kirby-Bauer technic.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002512:Cephalothin / Q000494:pharmacology; D004338:Drug Combinations; D005069:Evaluation Studies as Topic; D008712:Methicillin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests / Q000379:methods*; D013210:Staphylococcus / Q000187:drug effects*; D014640:Vancomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D014640:Vancomycin; D008712:Methicillin; D002512:Cephalothin